Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond

Journal of Molecular and Cellular Cardiology

Volumn 71, Issue , 2014, Pages 32-42

  Cui, Ziyou ^b   Scruggs, Sarah B ^a   Gilda, Jennifer E ^b   Ping, Peipei ^a   Gomes, Aldrin V ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetylation; Cardiovascular disease; Methylation; SUMOylation; Ubiquitin proteasome system; Ubiquitination

Indexed keywords

CASPASE; HEART ENZYME; LYSINE; METHYLGLYOXAL; N ACETYLGLUCOSAMINE; PROTEASOME; TYROSINE; UBIQUITIN;

ACETYLATION; ADENOSINE DIPHOSPHATE RIBOSYLATION; CARDIOVASCULAR DISEASE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; ENZYME MECHANISM; ENZYME MODIFICATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; NEDDYLATION; NITRATION; NITROSYLATION; NONHUMAN; OXIDATION KINETICS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN HOMEOSTASIS; PROTEIN METHYLATION; PROTEIN PROCESSING; REVIEW; SUMOYLATION; UBIQUITINATION; ANIMAL; ENZYMOLOGY; HEART MUSCLE; HOMEOSTASIS; METABOLISM;

ANIMALS; HOMEOSTASIS; HUMANS; MYOCARDIUM; PROTEASOME ENDOPEPTIDASE COMPLEX; SUMOYLATION; UBIQUITIN; UBIQUITINATION;

EID: 84899928291     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.10.008     Document Type: Review

References (148)

1. Goll D.E., Neti G., Mares S.W., Thompson V.F. Myofibrillar protein turnover: the proteasome and the calpains. J Anim Sci 2008, 86:E19-E35.
2. Schubert U., Anton L.C., Gibbs J., Norbury C.C., Yewdell J.W., Bennink J.R. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000, 404:770-774.
3. Xu G., Paige J.S., Jaffrey S.R. Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat Biotechnol 2010, 28:868-873.
4. Peters J.M. Proteasomes: protein degradation machines of the cell. Trends Biochem Sci 1994, 19:377-382.
5. Brooks P., Fuertes G., Murray R.Z., Bose S., Knecht E., Rechsteiner M.C., et al. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem J 2000, 346(Pt 1):155-161.
6. Gomes A.V., Zong C., Edmondson R.D., Li X., Stefani E., Zhang J., et al. Mapping the murine cardiac 26S proteasome complexes. Circ Res 2006, 99:362-371.
7. Pagan J., Seto T., Pagano M., Cittadini A. Role of the ubiquitin proteasome system in the heart. Circ Res 2013, 112:1046-1058.
8. Wang X., Li J., Zheng H., Su H., Powell S.R. Proteasome functional insufficiency in cardiac pathogenesis. Am J Physiol Heart Circ Physiol 2011, 301:H2207-H2219.
9. Willis M.S., Townley-Tilson W.H., Kang E.Y., Homeister J.W., Patterson C. Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease. Circ Res 2010, 106:463-478.
10. Su H., Wang X. The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective. Cardiovasc Res 2010, 85:253-262.
11. Day S.M. The ubiquitin proteasome system in human cardiomyopathies and heart failure. Am J Physiol Heart Circ Physiol 2013, 304:H1283-H1293.
12. Harris J.R. Release of a macromolecular protein component from human erythrocyte ghosts. Biochim Biophys Acta 1968, 150:534-537.
13. Harris J.R. The isolation and purification of a macromolecular protein component from the human erythrocyte ghost. Biochim Biophys Acta 1969, 188:31-42.
14. Cuervo A.M., Palmer A., Rivett A.J., Knecht E. Degradation of proteasomes by lysosomes in rat liver. Eur J Biochem 1995, 227:792-800.
15. Hendil K.B. The 19S multicatalytic "prosome" proteinase is a constitutive enzyme in HeLa cells. Biochem Int 1988, 17:471-477.
16. Baumeister W., Walz J., Zuhl F., Seemuller E. The proteasome: paradigm of a self-compartmentalizing protease. Cell 1998, 92:367-380.
17. Bochtler M., Ditzel L., Groll M., Hartmann C., Huber R. The proteasome. Annu Rev Biophys Biomol Struct 1999, 28:295-317.
18. Ehlinger A., Walters K.J. Structural insights into proteasome activation by the 19s regulatory particle. Biochemistry 2013, 52:3618-3628.
19. Chen X., Barton L.F., Chi Y., Clurman B.E., Roberts J.M. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell 2007, 26:843-852.
20. Li X., Amazit L., Long W., Lonard D.M., Monaco J.J., O'Malley B.W. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol Cell 2007, 26:831-842.
21. Li X., Lonard D.M., Jung S.Y., Malovannaya A., Feng Q., Qin J., et al. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Cell 2006, 124:381-392.
22. Cascio P., Call M., Petre B.M., Walz T., Goldberg A.L. Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes. EMBO J 2002, 21:2636-2645.
23. Scruggs S.B., Zong N.C., Wang D., Stefani E., Ping P. Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics. Am J Physiol Heart Circ Physiol 2012, 303:H9-H18.
24. Tsukamoto O., Minamino T., Kitakaze M. Functional alterations of cardiac proteasomes under physiological and pathological conditions. Cardiovasc Res 2010, 85:339-346.
25. Mogk A., Bukau B. Cell biology. When the beginning marks the end. Science 2010, 327:966-967.
26. Hwang C.S., Shemorry A., Varshavsky A. N-terminal acetylation of cellular proteins creates specific degradation signals. Science 2010, 327:973-977.
27. Glozak M.A., Sengupta N., Zhang X., Seto E. Acetylation and deacetylation of non-histone proteins. Gene 2005, 363:15-23.
28. Scott I. Regulation of cellular homoeostasis by reversible lysine acetylation. Essays Biochem 2012, 52:13-22.
29. Malik R., Nigg E.A., Korner R. Comparative conservation analysis of the human mitotic phosphoproteome. Bioinformatics 2008, 24:1426-1432.
30. Gnad F., Ren S., Cox J., Olsen J.V., Macek B., Oroshi M., et al. PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites. Genome Biol 2007, 8:R250.
31. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 2006, 23:607-618.
32. Wang D., Fang C., Zong N.C., Liem D.A., Cadeiras M., Scruggs S.B., et al. Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human 2013, Molecular & cellular proteomics, MCP.
33. Liu J., Wang Y., Li L., Zhou L., Wei H., Zhou Q., et al. Site-specific acetylation of the proteasome activator REGgamma directs its heptameric structure and functions. J Biol Chem 2013, 288:16567-16578.
34. Min L., Xu H., Wang J., Qu L., Jiang B., Zeng Y., et al. N-alpha-acetyltransferase 10 protein is a negative regulator of 28S proteasome through interaction with PA28beta. FEBS Lett 2013, 587:1630-1637.
35. Divald A., Kivity S., Wang P., Hochhauser E., Roberts B., Teichberg S., et al. Myocardial ischemic preconditioning preserves postischemic function of the 26S proteasome through diminished oxidative damage to 19S regulatory particle subunits. Circ Res 2010, 106:1829-1838.
36. DeMartino G.N. Purification of PA700, the 19S regulatory complex of the 26S proteasome. Methods Enzymol 2005, 398:295-306.
37. Ishii T., Sakurai T., Usami H., Uchida K. Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26S proteasome. Biochemistry 2005, 44:13893-13901.
38. Farout L., Mary J., Vinh J., Szweda L.I., Friguet B. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch Biochem Biophys 2006, 453:135-142.
39. Bulteau A.L., Lundberg K.C., Humphries K.M., Sadek H.A., Szweda P.A., Friguet B., et al. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 2001, 276:30057-30063.
40. Sun X.M., Butterworth M., MacFarlane M., Dubiel W., Ciechanover A., Cohen G.M. Caspase activation inhibits proteasome function during apoptosis. Mol Cell 2004, 14:81-93.
41. Jang M., Park B.C., Lee A.Y., Na K.S., Kang S., Bae K.H., et al. Caspase-7 mediated cleavage of proteasome subunits during apoptosis. Biochem Biophys Res Commun 2007, 363:388-394.
42. Demon D., Van Damme P., Vanden Berghe T., Deceuninck A., Van Durme J., Verspurten J., et al. Proteome-wide substrate analysis indicates substrate exclusion as a mechanism to generate caspase-7 versus caspase-3 specificity. Mol Cell Proteomics 2009, 8:2700-2714.
43. Sumegi M., Hunyadi-Gulyas E., Medzihradszky K.F., Udvardy A. 26S proteasome subunits are O-linked N-acetylglucosamine-modified in Drosophila melanogaster. Biochem Biophys Res Commun 2003, 312:1284-1289.
44. Zhang F., Su K., Yang X., Bowe D.B., Paterson A.J., Kudlow J.E. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 2003, 115:715-725.
45. Overath T., Kuckelkorn U., Henklein P., Strehl B., Bonar D., Kloss A., et al. Mapping of O-GlcNAc sites of 20S proteasome subunits and Hsp90 by a novel biotin-cystamine tag. Mol Cell Proteomics 2012, 11:467-477.
46. Trinidad J.C., Barkan D.T., Gulledge B.F., Thalhammer A., Sali A., Schoepfer R., et al. Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse. Mol Cell Proteomics 2012, 11:215-229.
47. Silva G.M., Netto L.E., Simoes V., Santos L.F., Gozzo F.C., Demasi M.A., et al. Redox control of 20S proteasome gating. Antioxid Redox Signal 2012, 16:1183-1194.
48. Giardino I., Edelstein D., Brownlee M. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J Clin Invest 1994, 94:110-117.
49. Queisser M.A., Yao D., Geisler S., Hammes H.P., Lochnit G., Schleicher E.D., et al. Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 2010, 59:670-678.
50. Yao D., Taguchi T., Matsumura T., Pestell R., Edelstein D., Giardino I., et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem 2007, 282:31038-31045.
51. Chen C., Nott T.J., Jin J., Pawson T. Deciphering arginine methylation: Tudor tells the tale. Nat Rev Mol Cell Biol 2011, 12:629-642.
52. Black J.C., Whetstine J.R. Tipping the lysine methylation balance in disease. Biopolymers 2013, 99:127-135.
53. Humbard M.A., Reuter C.J., Zuobi-Hasona K., Zhou G., Maupin-Furlow J.A. Phosphorylation and methylation of proteasomal proteins of the haloarcheon Haloferax volcanii. Archaea 2010, 2010:481725.
54. Osna N.A., White R.L., Donohue T.M., Beard M.R., Tuma D.J., Kharbanda K.K. Impaired methylation as a novel mechanism for proteasome suppression in liver cells. Biochem Biophys Res Commun 2010, 391:1291-1296.
55. Gomes A.V., Young G.W., Wang Y., Zong C., Eghbali M., Drews O., et al. Contrasting proteome biology and functional heterogeneity of the 20S proteasome complexes in mammalian tissues. Mol Cell Proteomics 2009, 8:302-315.
56. Chen G., Liu H., Wang X., Li Z. In vitro methylation by methanol: proteomic screening and prevalence investigation. Anal Chim Acta 2010, 661:67-75.
57. Johnson D.R., Bhatnagar R.S., Knoll L.J., Gordon J.I. Genetic and biochemical studies of protein N-myristoylation. Annu Rev Biochem 1994, 63:869-914.
58. Rudnick D.A., McWherter C.A., Gokel G.W., Gordon J.I. MyristoylCoA:protein N-myristoyltransferase. Adv Enzymol Relat Areas Mol Biol 1993, 67:375-430.
59. Kimura A., Kato Y., Hirano H. N-myristoylation of the Rpt2 subunit regulates intracellular localization of the yeast 26S proteasome. Biochemistry 2012, 51:8856-8866.
60. Xu J., Wang S., Zhang M., Wang Q., Asfa S., Zou M.H. Tyrosine nitration of PA700 links proteasome activation to endothelial dysfunction in mouse models with cardiovascular risk factors. PLoS One 2012, 7:e29649.
61. Seth D., Hausladen A., Wang Y.J., Stamler J.S. Endogenous protein S-nitrosylation in E. coli: regulation by OxyR. Science 2012, 336:470-473.
62. Kapadia M.R., Eng J.W., Jiang Q., Stoyanovsky D.A., Kibbe M.R. Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells. Nitric Oxide 2009, 20:279-288.
63. Murray C.I., Uhrigshardt H., O'Meally R.N., Cole R.N., Van Eyk J.E. Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay. Mol Cell Proteomics 2012, 11. [M111 013441].
64. Ullrich O., Reinheckel T., Sitte N., Hass R., Grune T., Davies K.J. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc Natl Acad Sci U S A 1999, 96:6223-6228.
65. Ventadour S., Jarzaguet M., Wing S.S., Chambon C., Combaret L., Bechet D., et al. A new method of purification of proteasome substrates reveals polyubiquitination of 20S proteasome subunits. J Biol Chem 2007, 282:5302-5309.
66. Vasilescu J., Zweitzig D.R., Denis N.J., Smith J.C., Ethier M., Haines D.S., et al. The proteomic reactor facilitates the analysis of affinity-purified proteins by mass spectrometry: application for identifying ubiquitinated proteins in human cells. J Proteome Res 2007, 6:298-305.
67. Isasa M., Katz E.J., Kim W., Yugo V., Gonzalez S., Kirkpatrick D.S., et al. Monoubiquitination of RPN10 regulates substrate recruitment to the proteasome. Mol Cell 2010, 38:733-745.
68. Uchiki T., Kim H.T., Zhai B., Gygi S.P., Johnston J.A., O'Bryan J.P., et al. The ubiquitin-interacting motif protein, S5a, is ubiquitinated by all types of ubiquitin ligases by a mechanism different from typical substrate recognition. J Biol Chem 2009, 284:12622-12632.
69. Chiangjong W., Sinchaikul S., Chen S.T., Thongboonkerd V. Calcium oxalate dihydrate crystal induced changes in glycoproteome of distal renal tubular epithelial cells. Mol Biosyst 2011, 7:1917-1925.
70. Montpetit M.L., Stocker P.J., Schwetz T.A., Harper J.M., Norring S.A., Schaffer L., et al. Regulated and aberrant glycosylation modulate cardiac electrical signaling. Proc Natl Acad Sci U S A 2009, 106:16517-16522.
71. Jones J., Wu K., Yang Y., Guerrero C., Nillegoda N., Pan Z.Q., et al. A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. J Proteome Res 2008, 7:1274-1287.
72. Shao R., Zhang F.P., Tian F., Anders Friberg P., Wang X., Sjoland H., et al. Increase of SUMO-1 expression in response to hypoxia: direct interaction with HIF-1alpha in adult mouse brain and heart in vivo. FEBS Lett 2004, 569:293-300.
73. Manza L.L., Codreanu S.G., Stamer S.L., Smith D.L., Wells K.S., Roberts R.L., et al. Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem Res Toxicol 2004, 17:1706-1715.
74. Guo D., Han J., Adam B.L., Colburn N.H., Wang M.H., Dong Z., et al. Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. Biochem Biophys Res Commun 2005, 337:1308-1318.
75. Golebiowski F., Matic I., Tatham M.H., Cole C., Yin Y., Nakamura A., et al. System-wide changes to SUMO modifications in response to heat shock. Sci Signal 2009, 2:ra24.
76. Wang J., Chen L., Wen S., Zhu H., Yu W., Moskowitz I.P., et al. Defective SUMOylation pathway directs congenital heart disease. Birth Defects Res Part A Clin Mol Teratol 2011, 91:468-476.
77. Banerjee A., Guttridge D.C. Mechanisms for maintaining muscle. Curr Opin Support Palliat Care 2012, 6:451-456.
78. Moser K., White F.M. Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS. J Proteome Res 2006, 5:98-104.
79. Meiners S., Ludwig A., Stangl V., Stangl K. Proteasome inhibitors: poisons and remedies. Med Res Rev 2008, 28:309-327.
80. Powell S.R., Divald A. The ubiquitin-proteasome system in myocardial ischaemia and preconditioning. Cardiovasc Res 2010, 85:303-311.
81. Predmore J.M., Wang P., Davis F., Bartolone S., Westfall M.V., Dyke D.B., et al. Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation 2010, 121:997-1004.
82. Weekes J., Morrison K., Mullen A., Wait R., Barton P., Dunn M.J. Hyperubiquitination of proteins in dilated cardiomyopathy. Proteomics 2003, 3:208-216.
83. Yang Y., Li C.C., Weissman A.M. Regulating the p53 system through ubiquitination. Oncogene 2004, 23:2096-2106.
84. Zhang H.G., Wang J., Yang X., Hsu H.C., Mountz J.D. Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 2004, 23:2009-2015.
85. Marfella R., Di Filippo C., Portoghese M., Siniscalchi M., Martis S., Ferraraccio F., et al. The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control. Cardiovasc Pathol 2009, 18:332-345.
86. Yang X.J., Seto E. Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell 2008, 31:449-461.
87. Lam M.P., Scruggs S.B., Kim T.Y., Zong C., Lau E., Wang D., et al. An MRM-based workflow for quantifying cardiac mitochondrial protein phosphorylation in murine and human tissue. J Proteomics 2012, 75:4602-4609.
88. Day S.M., Divald A., Wang P., Davis F., Bartolone S., Jones R., et al. Impaired assembly and post-translational regulation of 26S proteasome in human end-stage heart failure. Circ Heart Fail 2013, 6:544-549.
89. Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325:834-840.
90. Technology CS.PhosphoSite Plus p. PhosphoSitePlus (http://www.phosphosite.org) is an open, comprehensive, manually curated and interactive resource for studying experimentally observed post-translational modifications, primarily of human and mouse proteins 2013.
91. Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327:1000-1004.
92. Simon G.M., Cheng J., Gordon J.I. Quantitative assessment of the impact of the gut microbiota on lysine epsilon-acetylation of host proteins using gnotobiotic mice. Proc Natl Acad Sci U S A 2012, 109:11133-11138.
93. Mahrus S., Trinidad J.C., Barkan D.T., Sali A., Burlingame A.L., Wells J.A. Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 2008, 134:866-876.
94. Jung S.Y., Li Y., Wang Y., Chen Y., Zhao Y., Qin J. Complications in the assignment of 14 and 28Da mass shift detected by mass spectrometry as in vivo methylation from endogenous proteins. Anal Chem 2008, 80:1721-1729.
95. Zhan X., Desiderio D.M. Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry. Anal Biochem 2006, 354:279-289.
96. Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., et al. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 2008, 105:10762-10767.
97. Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 2010, 3:ra3.
98. Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K., et al. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2009, 2:ra46.
99. Lee S.H., Park Y., Yoon S.K., Yoon J.B. Osmotic stress inhibits proteasome by p38 MAPK-dependent phosphorylation. J Biol Chem 2010, 285:41280-41289.
100. Wu F., Wang P., Zhang J., Young L.C., Lai R., Li L. Studies of phosphoproteomic changes induced by nucleophosmin-anaplastic lymphoma kinase (ALK) highlight deregulation of tumor necrosis factor (TNF)/Fas/TNF-related apoptosis-induced ligand signaling pathway in ALK-positive anaplastic large cell lymphoma. Mol Cell Proteomics 2010, 9:1616-1632.
101. Benedict C.M., Clawson G.A. Nuclear multicatalytic proteinase subunit RRC3 is important for growth regulation in hepatocytes. Biochemistry 1996, 35:11612-11621.
102. Gu T.L., Deng X., Huang F., Tucker M., Crosby K., Rimkunas V., et al. Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One 2011, 6:e15640.
103. Lu H., Zong C., Wang Y., Young G.W., Deng N., Souda P., et al. Revealing the dynamics of the 20S proteasome phosphoproteome: a combined CID and electron transfer dissociation approach. Mol Cell Proteomics 2008, 7:2073-2089.
104. Shiromizu T., Adachi J., Watanabe S., Murakami T., Kuga T., Muraoka S., et al. Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the phosphositeplus database as part of the chromosome-centric human proteome project. J Proteome Res 2013, 12:2414-2421.
105. Christensen G.L., Kelstrup C.D., Lyngso C., Sarwar U., Bogebo R., Sheikh S.P., et al. Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists. Mol Cell Proteomics 2010, 9:1540-1553.
106. Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 2005, 23:94-101.
107. Sui S., Wang J., Yang B., Song L., Zhang J., Chen M., et al. Phosphoproteome analysis of the human Chang liver cells using SCX and a complementary mass spectrometric strategy. Proteomics 2008, 8:2024-2034.
108. Wang X., Chen C.F., Baker P.R., Chen P.L., Kaiser P., Huang L. Mass spectrometric characterization of the affinity-purified human 26S proteasome complex. Biochemistry 2007, 46:3553-3565.
109. Weber C., Schreiber T.B., Daub H. Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells. J Proteomics 2012, 75:1343-1356.
110. Feng Y., Longo D.L., Ferris D.K. Polo-like kinase interacts with proteasomes and regulates their activity. Cell Growth Differ 2001, 12:29-37.
111. Liu X., Huang W., Li C., Li P., Yuan J., Li X., et al. Interaction between c-Abl and Arg tyrosine kinases and proteasome subunit PSMA7 regulates proteasome degradation. Mol Cell 2006, 22:317-327.
112. Wisniewski J.R., Nagaraj N., Zougman A., Gnad F., Mann M. Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology. J Proteome Res 2010, 9:3280-3289.
113. Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., et al. System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal 2011, 4:rs3.
114. Moritz A., Li Y., Guo A., Villen J., Wang Y., MacNeill J., et al. Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci Signal 2010, 3:ra64.
115. Luo W., Slebos R.J., Hill S., Li M., Brabek J., Amanchy R., et al. Global impact of oncogenic Src on a phosphotyrosine proteome. J Proteome Res 2008, 7:3447-3460.
116. Ge F., Xiao C.L., Yin X.F., Lu C.H., Zeng H.L., He Q.Y. Phosphoproteomic analysis of primary human multiple myeloma cells. J Proteomics 2010, 73:1381-1390.
117. Eang R., Girbal-Neuhauser E., Xu B., Gairin J.E. Characterization and differential expression of a newly identified phosphorylated isoform of the human 20S proteasome beta7 subunit in tumor vs. normal cell lines. Fundam Clin Pharmacol 2009, 23:215-224.
118. Manes N.P., Dong L., Zhou W., Du X., Reghu N., Kool A.C., et al. Discovery of mouse spleen signaling responses to anthrax using label-free quantitative phosphoproteomics via mass spectrometry. Mol Cell Proteomics 2011, 10. [M110 000927].
119. Wilson-Grady J.T., Haas W., Gygi S.P. Quantitative comparison of the fasted and re-fed mouse liver phosphoproteomes using lower pH reductive dimethylation. Methods 2013, 61:277-286.
120. Choudhary C., Olsen J.V., Brandts C., Cox J., Reddy P.N., Bohmer F.D., et al. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol Cell 2009, 36:326-339.
121. Hsu P.P., Kang S.A., Rameseder J., Zhang Y., Ottina K.A., Lim D., et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011, 332:1317-1322.
122. Kim B.G., Lee J.H., Ahn J.M., Park S.K., Cho J.H., Hwang D., et al. 'Two-stage double-technique hybrid (TSDTH)' identification strategy for the analysis of BMP2-induced transdifferentiation of premyoblast C2C12 cells to osteoblast. J Proteome Res 2009, 8:4441-4454.
123. Schreiber T.B., Mausbacher N., Keri G., Cox J., Daub H. An integrated phosphoproteomics work flow reveals extensive network regulation in early lysophosphatidic acid signaling. Mol Cell Proteomics 2010, 9:1047-1062.
124. Wang Z., Udeshi N.D., Slawson C., Compton P.D., Sakabe K., Cheung W.D., et al. Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci Signal 2010, 3:ra2.
125. Herskowitz J.H., Seyfried N.T., Duong D.M., Xia Q., Rees H.D., Gearing M., et al. Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration. J Proteome Res 2010, 9:6368-6379.
126. Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K., Demol H., et al. Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC. Proteomics 2005, 5:3589-3599.
127. Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., Beausoleil S.A., et al. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 2010, 143:1174-1189.
128. Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F., Waidelich M., Longo D., et al. Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations. Mol Cell Proteomics 2007, 6:283-293.
129. Zhang F., Hu Y., Huang P., Toleman C.A., Paterson A.J., Kudlow J.E. Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J Biol Chem 2007, 282:22460-22471.
130. Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131:1190-1203.
131. Pighi C., Gu T.L., Dalai I., Barbi S., Parolini C., Bertolaso A., et al. Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. Cell Oncol (Dordr) 2011, 34:141-153.
132. Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P. Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci U S A 2007, 104:1488-1493.
133. Tatham M.H., Matic I., Mann M., Hay R.T. Comparative proteomic analysis identifies a role for SUMO in protein quality control. Sci Signal 2011, 4:rs4.
134. Matic I., Schimmel J., Hendriks I.A., van Santen M.A., van de Rijke F., van Dam H., et al. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Mol Cell 2010, 39:641-652.
135. Wu Y., Wang L., Zhou P., Wang G., Zeng Y., Wang Y., et al. Regulation of REGgamma cellular distribution and function by SUMO modification. Cell Res 2011, 21:807-816.
136. Kim W., Bennett E.J., Huttlin E.L., Guo A., Li J., Possemato A., et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 2011, 44:325-340.
137. Wagner S.A., Beli P., Weinert B.T., Nielsen M.L., Cox J., Mann M., et al. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics 2011, 10. [M111 013284].
138. Danielsen J.M., Sylvestersen K.B., Bekker-Jensen S., Szklarczyk D., Poulsen J.W., Horn H., et al. Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Mol Cell Proteomics 2011, 10. [M110 003590].
139. Shi Y., Chan D.W., Jung S.Y., Malovannaya A., Wang Y., Qin J. A data set of human endogenous protein ubiquitination sites. Mol Cell Proteomics 2011, 10. [M110 002089].
140. Wagner S.A., Beli P., Weinert B.T., Scholz C., Kelstrup C.D., Young C., et al. Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues. Mol Cell Proteomics 2012, 11:1578-1585.
141. Meierhofer D., Wang X., Huang L., Kaiser P. Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry. J Proteome Res 2008, 7:4566-4576.
142. Denis N.J., Vasilescu J., Lambert J.P., Smith J.C., Figeys D. Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry. Proteomics 2007, 7:868-874.
143. Bose S., Stratford F.L., Broadfoot K.I., Mason G.G., Rivett A.J. Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon. Biochem J 2004, 378:177-184.
144. Yano M., Mori S., Kido H. Intrinsic nucleoside diphosphate kinase-like activity is a novel function of the 20S proteasome. J Biol Chem 1999, 274:34375-34382.
145. Van Hoof D., Munoz J., Braam S.R., Pinkse M.W., Linding R., Heck A.J., et al. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 2009, 5:214-226.
146. Um J.W., Im E., Park J., Oh Y., Min B., Lee H.J., et al. ASK1 negatively regulates the 26S proteasome. J Biol Chem 2010, 285:36434-36446.
147. Satoh K., Sasajima H., Nyoumura K.I., Yokosawa H., Sawada H. Assembly of the 26S proteasome is regulated by phosphorylation of the p45/Rpt6 ATPase subunit. Biochemistry 2001, 40:314-319.
148. Li N., Lerea K.M., Etlinger J.D. Phosphorylation of the proteasome activator PA28 is required for proteasome activation. Biochem Biophys Res Commun 1996, 225:855-860.